Medullary thyroid cancer (MTC) is a rare yet aggressive form of thyroid cancer, accounting for 5–10% of all thyroid malignancies but disproportionately ...

Despite multimodality treatment for thyroid cancer ... role at least as part of a multimodality approach for advanced thyroid cancer. Gene therapy for thyroid cancer represents a new technology ...

The good news is that the risk for thyroid cancer linked to GLP-1 drugs appears low, but higher detections in the first year, ...

An estimated 42 million people in India suffer from thyroid problems, an autoimmune condition that has grown very common. The most frequent cause is thought to be iodine deficiency brought on by ...

Although not preferred for early-stage thyroid cancer, chemotherapy may be beneficial in advanced, aggressive cases. However, it comes with side-effects such as nausea, fatigue and hair loss ...

For more advanced cases, external radiation or targeted therapy may be employed.” Dr Manjunath Malige concluded, “Thyroid nodules and cancer cannot always be avoided but early identification ...

Patients with cancer found in distant structures have a 40% 10-year survival rate. Medullary thyroid cancer often does not cause symptoms or signs. Some patients with large nodules and/or advanced ...

Patients with thyroid cancer are generally treated with surgery. Although thyroid surgery is common, the best outcomes and lowest morbidity are generally achieved by surgeons with experience in this ...

The authors note that thyroid cancer mortality remained stable over ... become symptomatic and are a common autopsy finding) with advanced diagnostic and imaging techniques. Given the risk of ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...